Digitisation | May 01, 2023
Aptar Digital Health and Healint collaborate for Central Nervous System
The partnership will capitalize on the combined capabilities of the two organizations
The partnership will capitalize on the combined capabilities of the two organizations
Call it a major breakthrough for diagnostic imaging
Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
The LIFT-PD study will enroll 75 Parkinson’s patients experiencing apathy across 16 sites in Germany, Bulgaria, Poland and Spain
Fenebrutinib has the potential to become the first and only high-efficacy oral, brain-penetrant treatment for both RMS and PPMS, showing a profound benefit on relapsing and progressive disease biology
The drug targets relapsed or refractory primary central nervous system lymphoma, a rare and aggressive form of non-Hodgkin lymphoma
Alto met its enrollment goal with 83 patients across 13 US clinical sites
The recommendation is based on new data from continuous safety monitoring of medicines in the EU
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Subscribe To Our Newsletter & Stay Updated
